We defined the atrial strength-interval relation in 23 patients at cycle lengths of 600, 450, and 300 msec before and after procainamide. The atrial diastolic threshold was similar at cycle lengths of 600 and 450 msec, but the threshold at 300 msec was significantly higher than that determined at 600 and 450 msec both before and after procainamide. Procainamide significantly increased the diastolic threshold only at a cycle length of 300 msec. The strength-interval relation was nonlinear, showing progressively decreasing decrements in the measured refractory period as the stimulating current was increased. Progressive decreases in the drive cycle length from 600 to 450 to 300 msec caused similar decreases in refractory periods. The shape of the curves was similar at cycle lengths of 600 and 450 msec. However, at low current strengths, the slope of the curve determined at 300 msec was significantly more vertical than the slopes of the curves at the longer drive cycle lengths. Procainamide caused similar increases in apparent refractory periods at each paced cycle length. Procainamide did not alter the shape of the curves at any paced cycle length. These observations confirm the importance of stimulation frequency on atrial excitability. They suggest that the effects of procainamide on the effective refractory period of the atrium are not cycle length dependent, although the drug effects on threshold are dependent on the drive cycle length. (Circulation 1989;79:271-280) R efractoriness and excitability of cardiac tissue in humans are commonly measured by determination of effective refractory periods and diastolic stimulation threshold. Several factors are known to influence refractory periods, including stimulation rate, stimulation site, stimulus duration, strength, and polarity. One of the most important of these factors is the stimulus strength. The value of stimulus current strength can clearly influence the results of clinical and experimental studies. The relation between stimulus strength and the duration of the effective refractory period (the time during which a stimulus of a certain strength cannot evoke a propagated response) describes the recovery of excitability more completely than refractory period determination at a single current strength. This relation provides a means to interpret the signifi-cance of the common term x times the threshold current when measuring refractoriness.
We defined the atrial strength-interval relation in 23 patients at cycle lengths of 600, 450, and 300 msec before and after procainamide. The atrial diastolic threshold was similar at cycle lengths of 600 and 450 msec, but the threshold at 300 msec was significantly higher than that determined at 600 and 450 msec both before and after procainamide. Procainamide significantly increased the diastolic threshold only at a cycle length of 300 msec. The strength-interval relation was nonlinear, showing progressively decreasing decrements in the measured refractory period as the stimulating current was increased. Progressive decreases in the drive cycle length from 600 to 450 to 300 msec caused similar decreases in refractory periods. The shape of the curves was similar at cycle lengths of 600 and 450 msec. However, at low current strengths, the slope of the curve determined at 300 msec was significantly more vertical than the slopes of the curves at the longer drive cycle lengths. Procainamide caused similar increases in apparent refractory periods at each paced cycle length. Procainamide did not alter the shape of the curves at any paced cycle length. These observations confirm the importance of stimulation frequency on atrial excitability. They suggest that the effects of procainamide on the effective refractory period of the atrium are not cycle length dependent, although the drug effects on threshold are dependent on the drive cycle length. (Circulation 1989; 79:271-280) R efractoriness and excitability of cardiac tissue in humans are commonly measured by determination of effective refractory periods and diastolic stimulation threshold. Several factors are known to influence refractory periods, including stimulation rate, stimulation site, stimulus duration, strength, and polarity. One of the most important of these factors is the stimulus strength. The value of stimulus current strength can clearly influence the results of clinical and experimental studies. The relation between stimulus strength and the duration of the effective refractory period (the time during which a stimulus of a certain strength cannot evoke a propagated response) describes the recovery of excitability more completely than refractory period determination at a single current strength. This relation provides a means to interpret the signifi-cance of the common term x times the threshold current when measuring refractoriness.
The strength-interval relation is important because it describes basic physiologic properties of cardiac tissue. The strength-interval relation has been well described in the ventricle in animals and humans and in the atrium in animal experiments. However, the strength-interval relation in the atrium has not been described in humans. The purpose of the present study was to characterize the atrial strength-interval relation in humans and evaluate the influence of cycle length and procainamide on this property. We develop a method to describe the shape of the strength-interval curve, enabling statistical comparison of the effects of these interventions on its shape.
Methods

Patient Population
We studied 23 patients ranging in age from 25 to 74 years (mean, 57). Five patients had a history of atrial flutter or fibrillation. The indications for electrophysiologic study and the underlying cardiac diagnoses are delineated in Table 1 . All patients gave written, informed consent.
Definitions
Diastolic threshold was the minimal current resulting in consistent atrial "capture" at a constant paced cycle length. Atrial effective refi-actory period (ERP) was the longest S1S2 interval that failed to elicit a propagated response at a specified current strength. We use the term apparent ERP to emphasize that the measured value depends on the current strength of the stimulus. Responses were measured by bipolar intracardiac electrograms recorded from the catheters (see below).
Atrial absolute refractory period was the shortest refractory period observed on any strength-interval curve.
Atrial relative refractory period was estimated by two methods. The first method (referred to here as the "classic method") defined this value as the coupling interval at which increased current over the diastolic threshold was required to elicit a response by progressively premature stimuli. We arbitrarily chose this as the coupling interval at which a 0.5-mA increase in current was associated with decrease of 20 msec or less in measured refractory period. We chose these criteria to minimize artifactual changes in threshold due to shifts in catheter position. The duration of the relative refractory period was calculated by subtracting the absolute refractory period from this coupling interval where the curves switched from horizontal to relatively vertical. The second method (referred to as the electrophysiologic [EP] method) took the longest S1S2 interval at a stimulus strength equal to twice diastolic threshold at which latency (A1A2>S1S2) was observed. A1 and A2 are the atrial responses to the drive and premature stimuli (S1 and S2, respectively) measured where the first large rapid deflection of the atrial electrograms recorded from the proximal electrode pair of the quadripolar stimulating catheter crosses the baseline. Electrophysiologic Technique A 6F quadripolar catheter (interelectrode distance, 0.5 cm) was inserted percutaneously from a femoral vein and positioned under fluoroscopic guidance at the high right atrium. It was lodged firmly at the base of the right atrial appendage. The stability of the position was confirmed by visual observation and by reproduction of the threshold. Bipolar stimulation was performed with the distal electrode pair with the distal pole as cathode. Rectangular pulses 1 msec in duration with variable current strength were delivered by a custom-designed programma-ble stimulator (Bloom Associates, Reading, Pennsylvania). Current strength was determined by measuring the voltage across a 49.90-Q 1% resistor placed in series with the cathode. Surface electrocardiographic recordings of leads I, aVF, and V, were displayed simultaneously with an intracardiac atrial electrogram recorded from the proximal electrode pair. Recordings were amplified by an Electronics for Medicine Model VR16 recorder (Pleasantville, New York), displayed on a Tektronix dual time base oscilloscope (Beaverton, Oregon), and stored on magnetic tape (Model 5600C, Honeywell, Denver, Colorado).
Initially, late diastolic threshold was determined at paced cycle lengths of 600, 450, and 300 msec. Threshold was determined by increasing the current from zero until atrial "capture" occurred consistently (.15-20 consecutive stimuli) and then decreasing the current until consistent capture failed. The current was then increased again to the level at which capture consistently occurred. The latter value was taken as the threshold. Then, progressively premature atrial extrastimuli (S2) were delivered after eight paced complexes (S,) at each drive cycle length. The initial (longest) S1S2 interval depended on the drive cycle length: at a cycle length of 600 msec, the initial (longest) interval was 500 msec; at 450 msec, the initial interval was 400 msec; and at a cycle length of 300 msec, the initial interval was 290 msec. The S1S2 was decreased in 5-msec decrements until S2 failed to elicit a propagated response. Reproducibility of this effective refractory period was verified by multiple (at least two out of three) determinations before increasing the current. The ERP was initially determined at the threshold current. After determination of the effective refractory period at threshold, the current was increased to the next multiple of 0.5 mA and the S1S2 interval lengthened by 10 msec. The S1S2 interval was then decreased in 5 -msec decrements until it again failed to capture. Current was then increased in 0.5-mA increments with repeated determinations of the effective refractory period as described above to a maximum of 10 mA. In the last four patients studied, we increased the current in steps of 1 mA at levels above 5 mA. A 2-second pause was inserted after the eighth beat of each drive.
After determination of the strength-interval curves in the baseline state as described above, the relation was repeated in 17 patients after intravenous infusion of procainamide. A loading dose of procainamide was infused at a rate of 50 mg/min to a dose of 15 mg/kg. The infusion rate was then decreased to a maintenance rate of 0.11 mg/kg/min. Five minutes after the loading infusion had been terminated and the maintenance infusion begun, the determination of atrial threshold and strengthinterval curves was repeated at each paced cycle length exactly as in the baseline state. In all patients, a procainamide level was measured at the end of the the beginning (5 minutes after beginning the maintenance infusion) and end of stimulation. In these five patients, the mean difference in procainamide levels was 1.38 mg/l (range, 0.6-2.6 mg/l). Determination of each set of strength-interval curves (baseline and after procainamide) required [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] minutes.
Values are presented as mean±SD. Statistical analyses were performed with analysis of variance and paired t tests as appropriate. We compared the shape of the curves for each patient at each conditioning cycle length before and after procainamide administration by constructing a model. The model consisted of two line segments for each curve. Visual inspection of the curves suggested that the most appropriate intervals over which to construct the lines were from 0 to 3 mA and from 3.5 to 10 mA. Each straight line joined the values of refractoriness determined at threshold and 3 mA, and the values at 3.5 and 10 mA. The parameters examined for each line segment included the intercept and slope (see Appendix 1) . Initially, the hypotheses of equal curves were tested by the Hotelling T2 test.' This test compared the curves at each pacing rate before and after procainamide administration. The comparisons of the curve shapes at each paced cycle length in the baseline state and after procainamide administration were then made with regard to the slope and intercept of the segment from 0 to 3 mA and 3.5 to 10 mA with a paired t test as described above. The data for intercepts are not presented as they represent the obvious shifts in position of the curves associated with changes in cycle length and procainamide administration. The curve shapes are, therefore, approximated by the slopes of the two line segments in this model.
Results
Twenty-three patients were studied. Six were studied in the baseline state only. The remaining 17 were studied in the baseline state and after infusion of procainamide. In three patients, the strength-interval relation could not be completely determined at all cycle lengths before and after procainamide because of the repeated induction of atrial fibrillation or flutter. Thus, strength-interval curves were completed before and after procainamide in 14 patients. In the remaining three patients, atrial pacing thresholds only were determined at each paced cycle length in the baseline state and after procainamide. The mean serum procainamide level achieved was 9.6 ± 2.5 mg/l.
Effect of Drive Cycle Length and Procainamide on Atrial Threshold
In the baseline state and after procainamide infusion, the threshold at the atrial pacing site determined at paced cycle lengths of 600 and 450 msec were similar. However, both in the baseline state and after procainamide, the thresholds determined at 300 msec were significantly higher than the study. In five patients, levels were determined at threshold at either 66-0 or 450-ms-ec ( Figure 1 ). On the x axis are displayed the paced cycle lengths (PCL) in the baseline state and after procainamide administration. The threshold at a paced cycle length of 300 msec was higher than those determined at 600 and 450 msec in baseline and after procainamide. The threshold at 300 msec increased significantly after procainamide. There was no significant difference in the threshold before or afterprocainamide at cycle lengths of 600 and 450 msec.
Procainamide did not significantly alter the threshold at the atrial pacing site when determined at paced cycle lengths of 600 or 450 msec. However, there was a statistically significant increase (mean, 0.48±0.47 mA) in the threshold determined at a paced cycle length of 300 msec (p = 0.003).
Strength-Interval Relation
Increasing stimulation current permitted us to elicit propagated responses by progressively more premature stimuli. Thus, as the stimulating current was increased, the apparent refractory period decreased. This relation, however, was not linear (Figure 2 ). At low current strengths, small increments in current resulted in large decrements in the apparent effective refractory period. Thus, at relatively long coupling intervals, the curves had a horizontal position in most cases, especially at the cycle lengths of 600 and 450 msec (in 19 patients, the curve at 300 msec had no horizontal segment; see Figure 3 ). As the coupling interval of premature stimuli was decreased, at a certain point, each curve became relatively more vertical (Figures 2 and 3 ). That is, relatively small decrements in coupling interval resulted in continued failure to elicit propagated responses in spite of increasing stimulation current. The current strength at which the ERP came within 10 msec of the absolute refractory period was remarkably similar at each drive cycle length, ranging from 5.3 ± 1.7 mA at 600 msec to 5.9± 1.7 mA at 300 msec (p=NS).
As the drive cycle length was decreased from 600 to 450 and 300 msec, the apparent ERP measured at each level of current decreased; that is, the curves were shifted to the left (Figure 2 ). The change in apparent ERP at selected current strengths (threshold, twice threshold, 5 mA, and 10 mA) was similar when the drive cycle length was changed from 600 to 450 msec and from 450 to 300 msec ( Table 2) .
Analysis of the curve shapes before and after procainamide at each cycle length with the Hotelling T2 test revealed significant differences at each rate. However, analysis of the slopes of each of the five line segments between 0 and 3 mA and from 3.5 to 10 mA revealed no significant difference at each cycle length before and after procainamide. Thus, the differences revealed by the Hotelling T2 test were due only to shift in the position of the curves due to an increase in the refractory periods caused by procainamide. Analysis to determine whether the shape of the curves measured at a cycle length of 600 msec differed from those at 450 and 300 msec before and after procainamide revealed differences between the curve generated at 300 msec versus the other two cycle lengths ( Table 3 ). The slope of the first line segment (from 0 to 3 mA) determined at a cycle length of 300 msec differed significantly from the slopes of the segment determined at 600 and 450 msec ( Table 3 ). There was no significant difference in the slope of the first line segment between cycle length of 600 and 450 msec. The slope of the second line segment (from 3.5 to 10 mA), that of the vertical portion of the strength-interval curve, was not significantly affected by the drive cycle length ( Table 3) .
The effects of cycle length on the curves were evaluated further by comparing the duration of the relative refractory periods as determined by the classic method. The duration of the relative refractory period was calculated by subtracting the absolute refractory period from the value of the ERP at the point where the curve ceased being horizontal (see "Definitions"). There was no significant difference in the mean duration of the relative refractory period at any cycle length (Table 4 ). In addition, there was no relation between the threshold current and the relative refractory period.
A comparison of the two methods (classic vs. EP) of determining the relative refractory period in nine patients revealed them to be remarkably similar (Figure 4) . The EP method tended to overestimate the relative refractory period when compared with the classic method. In this patient, the curves at paced cycle lengths of 600 and 450 msec have horizontal portions at long coupling intervals. The curve determined at a paced cycle length of 300 msec lacks this horizontal portion. Note that the threshold (THR) determined at cycle length 300 msec is 0.3 mA higher than that determined at 600 msec and 0.2 mA higher than that determined at 450 msec (patient 2).
To better understand the mechanism underlying the increased diastolic threshold at a cycle length of 300 msec, we correlated the difference in thresholds at 600 and 300 msec with the curve shapes at the two cycle lengths. The difference in curve shape at two cycle lengths was estimated by the total change in ERPs from threshold to 10 mA at each cycle length. Thus, if the curves at 600 and 300 msec both had relatively long horizontal phases, the difference would be relatively less than if the curve determined at 600 msec had a long horizontal phase and the curve at 300 msec did not. We compared these differences to the difference in threshold between cycle lengths of 600 and 300 msec for each patient. The amount by which the threshold increased at a cycle length of 300 msec compared with 600 msec was strikingly related to the curve shape ( Figure 5 ). We dichotomized the relation into patients with changes in threshold between the two conditioning cycle lengths of 0.1 mA or less and those with 0.1 mA or more difference in threshold. Ten of 11 patients in which the difference in threshold between the two cycle lengths was 0.1 mA or less demonstrated 20 msec or less difference between 600 and 300 msec in the change in ERP from threshold to the absolute ERP. In contrast, only three of 16 patients with a difference in threshold between 600 and 300 msec of greater than 0.1 mA demonstrated 20 msec or less difference between the ERP at threshold Thr  2xThr  5 mA  10 mA  Thr  2xThr  5 mA  10 mA  600  287+46  245 +24  212±22  200±22  341+ 63  282±24  252± 20  228 ±17  450  279+46  230+24  197+21  182±21  324+62  260± 28  229+19  214+17  300  241+23  205+17  175±14  163±13  254+18  230±13  213+14 193+11 Values are mean + SD for effective refractory periods (msec). Thr, diastolic threshold. minus the absolute refractory period at 600 versus 300 msec (p<0.001).
Effects of Procainamide on Strength-Interval Curves
The strength-interval curves were shifted to the right after procainamide ( Figure 6 ). The degree of increase in ERPs was similar at each drive cycle length ( Table 2 ). The shape of the curves at each conditioning cycle length was not affected by procainamide as determined by the two-line approximation of the curve model. The difference in the slope of the line segment from 0 to 3 mA between cycle length of 300 msec and cycle lengths of 600 and 450 msec was accentuated after procainamide ( Table 3 ). In addition, the durations of the relative refractory periods were not altered by procainamide (Table 4 ). Finally, the current strengths at which the ERP came within 10 msec of the absolute refractory period remained unaffected by drive cycle length. They were unchanged from the baseline state, ranging from 6.5 ± 1.7 mA at 600 msec to 5.6± 1.9 mA at 300 msec.
Discussion
This study extends previous observations in experimental preparations and humans. We have shown that rate may influence diastolic threshold if the cycle length is short enough to impinge on the relative refractory period of the previous action potential. Procainamide has been shown to accentuate this effect of rate on threshold. We have also demonstrated that with decreasing cycle lengths over a range of 600 to 300 msec, the overall decrease in refractory period appears to be proportional both in the control state and after administration of procain-amide. Procainamide increased refractory periods to a similar degree at each cycle length tested.
Effects of Cycle Length on
Strength-Interval Relation
We used several methods to analyze the curve shapes. First, the point at which the ERP came within 10 msec of the absolute refractory period did not differ with drive cycle length before or after procainamide. Second, we compared the duration of the relative refractory period at each cycle length before and after procainamide. There was no significant difference in the durations of the relative refractory period at any cycle length. Finally, we constructed a two-line model of the curves. Visual examination of the curves initially suggested that in some patients the curve measured at a drive cycle length of 300 msec lacked the initial horizontal portion at low current strengths. The two-line model of the curves enabled us to analyze formally the curve shape at these low strengths by the slope of the first line segment (current levels, 0 to 3 mA). This analysis confirmed that the mean slope of the curve at current levels less than 3 mA was significantly different at a cycle length of 300 msec than at either 450 or 600 msec, both before and after procainamide. The differences were more striking after procainamide.
We did not find any influence of the threshold value on apparent refractory periods. However, analysis correlating the difference in threshold between cycle lengths of 300 and 600 msec with the difference in the duration of the curves from threshold to absolute refractory period demonstrated a relationship between these two factors. Thus, patients with a significant increase in threshold at 300 msec compared with 600 msec drive cycle length are more likely to have relatively steep strength-interval curves at 300 msec cycle length and "normal" curves at 600 msec (with a long horizontal phase at long coupling intervals). This suggests that the increase in threshold observed at the drive cycle length of 300 msec is due to impingement on the relative refractory period of the preceding action potential for the stimulated area in the high right atrium.
The relative refractory period reflects the recovery of excitability, and this in turn is influenced by the shape and duration of the action potential as well as by the kinetics of recovery from drug blockade and inactivation of the sodium channel. The mechanism underlying the increase in threshold at the higher rate is likely to be due to either a shift in the takeoff potential of the premature action potential or incomplete recovery of the activation kinetics of the sodium current or both. The accentuation of the increase in threshold at the drive cycle length of 300 msec suggests that the latter plays some role, but we cannot discount the former explanation either, because we were able to measure only refractory periods and not action potential duration directly. Accentuation of the increase in threshold at the 300-msec drive cycle length after procainamide is also compatible with either mechanism. Procainamide has been shown to increase both the absolute and relative refractory periods of canine atria.2 The action potential duration of canine Purkinje fibers is increased by procainamide,3 and the shape of the repolarization curve is altered. 4 We are not aware of similar data for procainamide effects on . Plots of comparison of two methods for determining the relative refractory period. The electrophysiologic (EP) method value for relative refractory period is shown on the x axis, and the relative refractory period (RP) determined from the classic method is shown on the y axis.
the atria. Use-dependent changes in the duration of the ERP out of proportion to prolongation of action potential duration have been demonstrated for procainamide in canine Purkinje fibers.3,4 Quinidine has been shown recently to have use-dependent effects on the duration of the refractory period of atrial tissue, and similar effects would be expected from procainamide,5 but we are not aware of similar data for procainamide in atrial tissue. Numerous investigators have examined the relation between cardiac excitability and stimulus strength and frequency in various animal preparations. This relation has been examined in the atria6-8 and, more extensively, in the ventricle.9-12 These studies have demonstrated consistently a decrease in refractory periods as stimulation frequency is increased. 13 The primary mechanism responsible for the adaptation of rate to refractoriness appears to be shortening of the action potential duration with increasing rates.1112 As the stimulation rate is increased, the time course of recovery of excitability changes, and at rapid rates (such as at a cycle length of 300 msec) membrane recovery is incomplete.1' This fact may explain the difference in the slope of the strength-interval curve at longer coupling intervals, and the increase in threshold we observed in many patients while pacing at a cycle length of 300 msec.
Our observations of the effect of rate on refractoriness are very similar to those noted in animal preparations. We observed comparable decreases in refractoriness as the drive cycle length was decreased from 600 to 450 to 300 msec. However, . Plots of relations between the difference in diastolic threshold at paced cycle lengths of 600 and 300 msec (recorded on the x axis) and the difference between the duration of the strength interval curves at 600 and 300 msec (displayed on the y axis). Increasing differences in threshold at the two cycle lengths are associated with increasing differences in the duration of the curves (or differences in the amount ofchange in effective refractory period [RP]from threshold to 10 mA at each cycle length).
(See text for explanation.) The X2 analysis demonstrates that using cut-off values for differences in threshold of0.1 mA and differences in the duration ofthe refractoryperiod (A RP) of20 msec, 10 ofi1 patients who had differences in threshold at the two cycle lengths of .0.1 mA had .20 msec difference in the change in refractorinessfrom threshold to 10 mA at 600 versus 300 msec. the durations of the relative refractory periods did not appear to be influenced by the drive cycle length (Table 4 ). Thus, the duration of the relative refractory period was proportionately greater at a cycle length of 300 msec than at 450 or 600 msec. Thus, there appears to be an absence of rate adaptation of the atrial relative refractory period as measured by our technique. Furthermore, the shape of the 4'lower" portion of the curve, reflecting stimulation at currents of 0-3 mA, differed at a cycle length of 300 msec. This observation, and the increase in stimulation threshold observed at a cycle length of 300 msec, suggests that at these rates recovery is still incomplete. Clinical electrophysiologists conventionally measure the atrial relative refractory period by the value at which a premature impulse propagates with latency to a nearby recording site (usually the proximal electrode pair on the catheter used for stimulation) at twice diastolic threshold. We compared this value to an estimate of relative refractory period derived from the strength-interval relation: the coupling interval at which increased current over the diastolic threshold was required to elicit a response by progressively premature stimuli. These two measures showed a remarkable correlation, suggesting that latency as measured clinically is due to impingement on the atrial relative refractory period. It should be noted that latency measured in this manner is a complex phenomenon that involves latency of turn-on of the depolarizing currents that initiate propagation as the stimulus site, in addition to delay in conduction time to the recording site.
Effect of Procainamide
The strength-interval curves generated after administration of procainamide showed a shift to the right at cycle lengths of 600 and 450 msec. In addition, at the cycle length of 300 msec, we demonstrated an upward shift due to a further increase in stimulation threshold. Similar frequency-dependent increases in threshold were noted by Johnson and McKinnon14 after quinidine in guinea pig ventricles, although in their studies, the effects were seen at rates as low as 100/min. It is interesting to note that the effects of procainamide on refractoriness appeared to be similar at each drive cycle length, not showing a greater increase at the shortest drive cycle length of 300 msec. This differs from the results of Nattel and Zeng15 who noted an increased prolongation of refractoriness in Purkinje fibers by quinidine at high stimulation rates. However, our results are similar to those of Marchlinski and Shinnar.16 These investigators, studying the effects of procainamide on human ventricular refractoriness, found no significant cycle length dependency.
Our observations extend those of Plumb et al,17 who studied the atria of patients undergoing open heart surgery. Using fixed electrodes, these investigators demonstrated a clearcut increase in pacing threshold with increases in rate. Their studies did not examine atrial refractoriness. Previous studies of the strength interval relation in humans have been limited to the ventricle.18,19 These studies did not note an effect of frequency on threshold, but they did not study rates corresponding to a cycle length of 300 msec. The effects on the duration of refractoriness both in the baseline state19 and after procainamide18 were remarkably similar to the present studies in human atria.
Technical Limitations
We cannot be certain that both electrodes maintained the exact same degree of contact with the atrial myocardium throughout the study. Nonetheless, the thresholds were examined at the beginning and end of each refractory period determination and remained stable. In addition, the catheter position was confirmed with fluoroscopy throughout the studies.
It is likely that the eight beat "drives" used in these studies do not allow a stable steady state of refractoriness to develop. Others studying the His-Purkinje system have documented that many more cycles are required to obtain a steady state.13 However, a recent study by Soni et a120 has demonstrated an apparent fundamental difference in the behavior of atrial tissue compared with ventricular and Purkinje tissue. This study has demonstrated that abrupt changes in cycle length cause immediate changes in atrial refractoriness. Thus, we cannot be certain that our observations occurred during a steady state. Nonetheless, the consistency of the curves at the various cycle lengths in the absence and presence of procainamide suggests that relatively stable status was maintained for the duration of the studies. It is possible that because most patients develop an atrioventricular (AV) Wenckebach phenomenon while pacing the atria at a cycle length of 300 msec, a varying AV relation could cause hemodynamic alterations influencing our results. We cannot discount this possibility. However, the degree of AV block and the portion of the eight beat drive in which the Wenckebach phenomenon occurred were not constant. Thus, this should not alter the results in a consistent manner.
There are limits to which the results of animal experiments may be compared with the present studies. Fundamental differences exist between our technique for measuring excitability and those used in animal preparations. Our electrodes are not as closely spaced as is possible in animal experiments, and the electrode characteristics are different. In the present study, the current strength during the drive or conditioning cycle was increased as the current of the extrastimulus increased. However, at the low current strengths where most changes in measured refractory periods occurred, both the drive and extrastimulus current were relatively low. Thus, the results are not likely to be significantly altered by this difference in technique. Clinical Implications These observations may have significant clinical relevance. Excitability of the atria is a fundamental electrophysiologic property that is frequently measured in evaluating the mechanisms underlying arrhythmias and the effects of antiarrhythmic agents. No previous studies have systematically examined the atrial strength-interval relation in humans over the range of cycle lengths performed in this study. The strength-interval relation at cycle lengths of 600 and 450 msec influences the ability to induce tachyarrhythmias by programmed stimulation that is commonly performed at these cycle lengths. The observations at the shorter drive cycle length of 300 msec are important in that this is a cycle length more closely approximating that of many atrial tachyarrhythmias, especially atrial flutter. Impingement of a propagated wavefront on tissue refractoriness in a reentrant circuit with a cycle length approximating 300 msec may explain oscillations in cycle length
The relatively broad horizontal portion of the curve observed at relatively low current strengths that are in the range of those commonly used to perform programmed stimulation shows that small changes in current may produce relatively large changes in apparent refractory periods over this range. This may influence the evaluation of the effect of drugs on refractory periods and suggests that evaluation of alterations in refractory periods produced by drugs should be performed at currents in the more vertical portion of the curve (i.e., at 5 mA).
Finally, delineation of the effect of rate on threshold carries implications for the development and testing of antitachycardia pacing devices that commonly use high stimulation rates. Evaluation of the diastolic threshold of such devices should be checked at the rates at which stimulation is planned. Acknowledgments We are indebted to Dr. Joseph Spear for his review and thoughtful comments on the manuscript and to Elizabeth A. Lomis for secretarial assistance.
Appendix 1 Description of Statistical Methods
The individual patient strength-interval curves were reduced to a relatively small number of manageable statistics by creating a model of the curves. For analysis of the model, refractory intervals were placed on the y axis and pacing current on the x axis (Figure 7) . The profiles of the curves were approximated by a straight line over the interval (0, 3 mA) and a second straight line over the interval (3.5, 10 mA). The parameters of the approximating line segments were intercept and slope. The intercept was taken as the ERP at a current level of 1 mA and at 7 mA for line segments 1 and 2, respectively. The slope of each line segment was determined by the slope of a line connecting the two extreme points (0, 3 mA for line segment 1, and 3.5, 10 mA for line segment 2). The choice of the intervals was suggested by the appearance of the data profiles.
The hypothesis that the curves derived from data during the baseline state and after procainamide administration were equivalent at a given pacing rate would be approximated by the hypothesis that the population means of the differences of the four Pacing Current t (mA) and spontaneous termination of tachyarrhythmias.21 FIGURE 7 . Slope of line segments. parameters (intercepts and slopes for the two line segments) between the baseline and procainamide states were simultaneously equal to 0. The hypotheses of equal curves were tested by the Hotelling T2 test.1 At each pacing rate, the comparison of baseline and procainamide states was significantly different: 0.05 >p > 0.025 Although the differences are statistically significantly different, this test could not distinguish between differences in pairs of curves (before and after procainamide at each rate) because of differences in the intercept versus the slope of each line segment.
We then calculated the slope of each profile segment at 0.5-mA current for 3 mA or less for each patient under baseline and procainamide conditions. These segments corresponded to the following intervals of current (T): T< 1, 1 <T< 1.5, 1.5 < T <2 2 < T < 2.5, and 2.5 < T < 3. The differences in slopes for each of these subdivisions of line segment 1 (0-3 mA) were compared between the baseline and procainamide conditions. There was no statistically significant difference between the procainamide and baseline conditions for any of these slopes.
We then compared the curve shapes for the different pacing rates under the baseline and procainamide conditions. The slopes and intercepts of line segments 1 and 2 were compared with a paired t test for each parameter.
